These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6480193)
21. Effects of ascorbate on leucocytes: Part I. Effects of ascorbate on neutrophil motility and intracellular cyclic nucleotide levels in vitro. Anderson R; Theron A S Afr Med J; 1979 Sep; 56(10):394-400. PubMed ID: 233044 [TBL] [Abstract][Full Text] [Related]
22. Ascorbic acid inhibits polymorphonuclear leukocytes influx to the place of inflammation--possible protection of lung from phagocyte-mediated injury. Nowak D; Ruta U; Piasecka G Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):213-8. PubMed ID: 2619505 [TBL] [Abstract][Full Text] [Related]
24. An in-vitro study of oral therapeutic doses of co-trimoxazole and erythromycin stearate on abnormal polymorphonuclear leucocyte migration. Ras GJ; Anderson R J Antimicrob Chemother; 1986 Feb; 17(2):185-93. PubMed ID: 3486178 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of human leukocyte metabolism and random mobility by local anaesthesia. Hammer R; Dahlgren C; Stendahl O Acta Anaesthesiol Scand; 1985 Jul; 29(5):520-3. PubMed ID: 2994345 [TBL] [Abstract][Full Text] [Related]
26. Defective responsiveness to ascorbic acid of neutrophil random and chemotactic migration in Felty's syndrome and systemic lupus erythematosus. Goetzl EJ Ann Rheum Dis; 1976 Dec; 35(6):510-5. PubMed ID: 1008618 [TBL] [Abstract][Full Text] [Related]
27. Effects of ascorbate on leucocytes: Part II. Effects of ascorbic acid and calcium and sodium ascorbate on neutrophil phagocytosis and post-phagocytic metabolic activity. Anderson R S Afr Med J; 1979 Sep; 56(10):401-4. PubMed ID: 95138 [TBL] [Abstract][Full Text] [Related]
28. Benoxaprofen inhibits the adhesion of human monocytes to cultured vascular endothelium. Brown KA; Ferrie J; Wilbourn B; Dumonde DC Agents Actions; 1989 Aug; 28(1-2):115-20. PubMed ID: 2782221 [TBL] [Abstract][Full Text] [Related]
29. Comparative effects of inhibitors of the lipoxygenase enzyme system on leucocyte chemotaxis. Kitchen EA; Dawson W J Pharm Pharmacol; 1984 May; 36(5):300-4. PubMed ID: 6145764 [TBL] [Abstract][Full Text] [Related]
30. Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes. Stevens DL; Mitten J; Henry C J Infect Dis; 1987 Aug; 156(2):324-33. PubMed ID: 2885383 [TBL] [Abstract][Full Text] [Related]
31. Effect of rokitamycin on human polymorphonuclear leukocyte chemotaxis. Torre D; Broggini M; Rossi S; Sampietro C; Bottà V Int J Tissue React; 1989; 11(1):27-9. PubMed ID: 2807774 [TBL] [Abstract][Full Text] [Related]
32. Increased leucoattractant binding and reversible inhibition of neutrophil motility mediated by the peroxidase/H2O2/halide system: effects of ascorbate, cysteine, dithiothreitol, levamisole and thiamine. Anderson R; Jones PT Clin Exp Immunol; 1982 Feb; 47(2):487-96. PubMed ID: 7075031 [TBL] [Abstract][Full Text] [Related]
33. Effects of ascorbate on leucocytes: Part III. In vitro and in vivo stimulation of abnormal neutrophil motility by ascorbate. Anderson R; Theron A S Afr Med J; 1979 Sep; 56(11):429-33. PubMed ID: 550365 [TBL] [Abstract][Full Text] [Related]
34. Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. Bass DA; Olbrantz P; Szejda P; Seeds MC; McCall CE J Immunol; 1986 Feb; 136(3):860-6. PubMed ID: 3001188 [TBL] [Abstract][Full Text] [Related]
35. Ascorbate-mediated stimulation of neutrophil motility and lymphocyte transformation by inhibition of the peroxidase/H2O2/halide system in vitro and in vivo. Anderson R Am J Clin Nutr; 1981 Sep; 34(9):1906-11. PubMed ID: 7282616 [TBL] [Abstract][Full Text] [Related]
36. Levamisole stimulation of neutrophil chemotaxis and chemokinesis by protection of both the leucoattractant and the cellular chemotactic response from inactivation by the peroxidase/hydrogen peroxide/halide system in vitro. Anderson R Int Arch Allergy Appl Immunol; 1981; 65(3):257-65. PubMed ID: 6263800 [TBL] [Abstract][Full Text] [Related]
37. Functional and metabolic studies of polymorphonuclear leukocytes in the congenital Pelger-Huet anomaly. Johnson CA; Bass DA; Trillo AA; Snyder MS; DeChatelet LR Blood; 1980 Mar; 55(3):466-9. PubMed ID: 6244014 [TBL] [Abstract][Full Text] [Related]
38. An in vivo and in vitro investigation of the phototoxic potential of tenoxicam, a new non-steroidal anti-inflammatory agent. Anderson R; Eftychis HA; Weiner A; Findlay GH Dermatologica; 1987; 175(5):229-34. PubMed ID: 3678549 [TBL] [Abstract][Full Text] [Related]
39. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. Bass DA; Parce JW; Dechatelet LR; Szejda P; Seeds MC; Thomas M J Immunol; 1983 Apr; 130(4):1910-7. PubMed ID: 6833755 [TBL] [Abstract][Full Text] [Related]
40. Modification of polymorphonuclear leucocyte function by imidazoles. Rowan-Kelly B; Ferrante A; Thong YH Int J Immunopharmacol; 1984; 6(4):389-93. PubMed ID: 6090323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]